Newsfeeds Archive - Spark Newswire

4 minute read

Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

May 15, 1:38 PM

Shares of Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) fell sharply during Wednesday’s session after the company reported first-quarter financial results.…

AEMD

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

May 15, 12:31 PM

Gainers SINTX Techs (NASDAQ:SINT) stock moved upwards by 136.2% to $0.13 during Wednesday’s regular session. The company’s market…

AEMD

1 minute read

This Accenture Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Today

By Avi Kapoor

May 15, 8:24 AM

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…

ACN

2 minute read

Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket

By Avi Kapoor

May 15, 8:14 AM

Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) rose sharply in today’s pre-market trading after the company reported better-than-expected first-quarter…

AEMD

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Pre-Market Session

By Benzinga Insights

May 15, 8:06 AM

Gainers SINTX Techs (NASDAQ:SINT) stock moved upwards by 143.1% to $0.13 during Wednesday’s pre-market session. The company’s market…

AEMD

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

May 14, 4:31 PM

Gainers Arcutis Biotherapeutics (NASDAQ:ARQT) stock moved upwards by 16.4% to $9.46 during Tuesday’s after-market session. The company’s market…

AKLI

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

April 3, 4:31 PM

Gainers Aesthetic Medical Intl (NASDAQ:AIH) shares rose 14.0% to $0.52 during Wednesday’s after-market session. The company’s market cap…

ACOR

4 minute read

Bolt Biotherapeutics Presents Updated Clinical Data From Phase 1 Dose-Escalation Trial Of BDC-1001 As Monotherapy And In Combination With Nivolumab In HER2-Expressing Tumors At ESMO 2023 Congress

By Benzinga Newsdesk

October 23, 10:32 AM

Updated safety data supports the selection of 20 mg/kg q2w as the recommended Phase 2 dose (RP2D) Improved efficacy with one partial response (PR) improving to a complete response (CR), two additional patients with

BOLT

2 minute read

Why AERWINS Technologies Shares Are Trading Higher By Around 90%; Here Are 20 Stocks Moving Premarket

By Lisa Levin

October 2, 8:11 AM

Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares rose 90.2% to $0.2297 in pre-market trading. Aerwins Technologies is considering strategic alternatives for non-core operations including, not limited to possible sale/other disposition of assets.

ACAQ

8 minute read

Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

September 29, 2:09 PM

Friday's session saw 112 companies set new 52-week lows.

AADI